NCT07578558Phase 2Withdrawn

NAI for Sepsis With Persistent Lymphopenia

Study sponsor: ImmunityBio, Inc. · IBRX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-08-03Estimated
Enrollment · participants0Actual
Source updated2026-11-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 50 participants (planned). After: 0 participants (actual).

Recruitment status changed

Before: Not yet recruiting. After: Withdrawn.

Check registry source